Cellular, Tissue, and Gene Therapies Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments - Biologics License Application (BLA) 125842 From Capricor, Inc. for Deramiocel (Human Allogeneic Cardiosphere-Derived Cells)
FDA_FRDOC_0001-14327Notice
Comments
199
Awaiting comments
Deadline
Closed on Jul 29, 2026
Closed Jul 29, 2026
Net supportiSupport minus oppose · campaigns included
—
Document
Details
The document's own metadata, straight from the source system.
- Title
- Cellular, Tissue, and Gene Therapies Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments - Biologics License Application (BLA) 125842 From Capricor, Inc. for Deramiocel (Human Allogeneic Cardiosphere-Derived Cells)
- Posted
- Jun 29, 2026
- Comment period
- Jun 29, 2026 – Jul 29, 2026
- FR Doc
- 2026-13096
- Topics
Analysis
Overview
What the public is saying — stance, who's commenting, and the issues they raise.
Include campaigns
Analyzed 0 of 199 comments
0%· analysis in progress
Stance breakdown
—
Net support
Not yet analyzed199
Who commented
Breakdown by commenter type.
Not yet analyzed
199
Issues raised
The docket's canonical issues. Select one to browse its comments.
Issues are identified as comment analysis progresses — nothing tagged on this document yet.
Comments
Explorer
Every mirrored comment — filter by stance, campaign, or issue.
Filter:
No comments match.
